In case you missed it: August 8 to August 12
A look back at the week's top stories.
Vivjoa approved for recurrent vulvovaginal candidiasis
Oteseconazole is a treatment option for those living with a previously unmet medical need.
Essentials of vulvovaginal dermatology
Correct terms and education can help normalize the conversation for patients.
Neighborhood disadvantage and fertility rates
Residing in a socioeconomically disadvantaged neighborhood was linked to moderately decreased fecundability, according to a study published in JAMA Network Open.
Maternal mortality before and during COVID pandemic
Maternal deaths in the United States rose by a staggering 33% after the onset of the COVID-19 pandemic in March 2020, which is a significantly higher percentage than the 22% overall excess death estimate linked to the pandemic, according to a research letter published in JAMA Network Open.
Monkeypox vaccine gets emergency approval to increase vaccine supply
Smaller dose given by intradermal injection creates five-fold increase in total supply, FDA says.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
